Evaluation of a Virtual Bioptic Telescope and Virtual Projection - - PowerPoint PPT Presentation

evaluation of a virtual bioptic telescope and virtual
SMART_READER_LITE
LIVE PREVIEW

Evaluation of a Virtual Bioptic Telescope and Virtual Projection - - PowerPoint PPT Presentation

Evaluation of a Virtual Bioptic Telescope and Virtual Projection Screen for Low Vision Patients ASHLEY DEEMER, OD WILMER EYE INSTITUTE JOHNS HOPKINS SCHOOL OF MEDICINE Disclosures I have no financial disclosures Visionize, LLC was involved


slide-1
SLIDE 1

Evaluation of a Virtual Bioptic Telescope and Virtual Projection Screen for Low Vision Patients

ASHLEY DEEMER, OD

WILMER EYE INSTITUTE JOHNS HOPKINS SCHOOL OF MEDICINE

slide-2
SLIDE 2

Disclosures

I have no financial disclosures Visionize, LLC was involved in providing equipment for the study

slide-3
SLIDE 3

Purpose

§Magnification is used to compensate for reduced visual acuity §Using a head-mounted display equipped with a high- resolution video camera, we can employ virtual reality methods to magnify images in real time §Existing head-mounted display units magnify the entire view and with high levels of magnification, image movement becomes problematic §Here we test a virtual bioptic telescope and virtual projection screen as an innovative approach to magnification

slide-4
SLIDE 4

Iris Vision

slide-5
SLIDE 5

Virtual Bioptic

slide-6
SLIDE 6

Virtual Projection Screen

slide-7
SLIDE 7

Home Trial

  • Observational study – aimed to determine if these

approaches to magnification are beneficial to low vision patients performing ADLs

  • 30 participants were recruited from the Low Vision Center

at the Wilmer Eye Institute

  • 13 female, 17 male
  • Mean age 53 years old, Age range 19-93
  • BCVA <20/100 in the better-seeing eye
  • Acuity ranged from 20/100 to 20/400
  • Bilateral central scotomas with normal peripheral VF
slide-8
SLIDE 8

Home Trial

  • All participants had prior exposure to low vision services

and were experienced visual assistive equipment users

  • The participants had basic operational training for 30-45

min in clinic

  • Then took the system home for a 7-10 day trial
slide-9
SLIDE 9

Outcome Measures

  • The Activity Inventory (AI) was administered before and

after the home-trial to measure effect on self-reported visual function

  • Simulator sickness questionnaire and system-use survey

were administered twice by telephone during the trial period

  • Baseline and follow-up AI results were analyzed using a

Rasch model

slide-10
SLIDE 10

Results – Effect Size

  • 0.2

0.2 0.4 0.6 0.8 1 1.2 1.4 Goals Reading Mobility Vis Info Vis Motor Outside Home Inside Home Effect Size Visual Abiliity Domain

slide-11
SLIDE 11

Results – Minimal Clinically Important Difference (MCID)

Domain MCID frequency % of participants Goals 69.0% Visual Info 86.2% Reading 85.7% Outside Home 78.6% Inside Home 72.4% Mobility 45.5% Visual Motor 44.0%

slide-12
SLIDE 12

Simulator Sickness Questionnaire

slide-13
SLIDE 13

Simulator Sickness Questionnaire

  • 5 patients (17%) reported headache
  • 4 patients (13%) reported symptoms of nausea
  • 11 patients (38%) reported experiencing eye strain
  • 7 patients (24%) “barely”
  • 2 patients (7%) “moderately”
  • 2 patients (7%) “very”
slide-14
SLIDE 14

System-Use Survey

  • Each participant was asked “How useful did you find the device?”
  • The average ordinal patient rating was 7.14/10
  • 17 (57%) of the patients said they would be interested in purchasing the

device for their personal use

slide-15
SLIDE 15

Conclusions

  • The use of this virtual bioptic system / virtual projection screen resulted

in improvements in visual function in the following domains:

  • Visual Information
  • Reading
  • Outside the home tasks
  • Inside the home tasks
  • Goals
  • The system was not effective for improving mobility and visual motor

function

slide-16
SLIDE 16

Conclusions

  • Overall, this group of experienced visual assistive device users found

this method of magnification to be effective in their daily activities

  • Over half of the participants found the device to be useful enough to

consider purchasing

  • A small, but significant number of participants reported symptoms of

discomfort while using the device

slide-17
SLIDE 17

Thank you

Collaborators: Bob Massof James Deremeik Chris Bradley Kyoko Fujiwara Frank Werblin Nicole Ross Danielle Natale Visionize, LLC Reader’s Digest Partners for Sight Foundation Grant

Contact Information: Ashley Deemer adeemer1@jhmi.edu